Reversible osimertinib-associated heart failure mimicking cancer recurrence in EGFR-mutated non-small cell lung cancer after pneumonectomy: A case report
Hirona Yokoyama, Nobuhito Hara, Rika Sasaki, Yumi Yoshii, Masahide Ota, Shunsuke Okazaki, Hitoshi Nakagawa, Takeshi Kawaguchi, Masatsugu Hamaji, Yuji Nitta, Maiko Takeda, Masayuki Takeda · 2026
Read Reversible osimertinib-associated heart failure mimicking cancer recurrence in EGFR-mutated non-small cell lung cancer after pneumonectomy: A case report by Hirona Yokoyama, Nobuhito Hara, Rika Sasaki, Yumi Yoshii, Masahide Ota, Shunsuke Okazaki, Hitoshi Nakagawa, Takeshi Kawaguchi, Masatsugu Hamaji, Yuji Nitta, Maiko Takeda, Masayuki Takeda (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13639783.txt.
Description
Yokoyama and co-authors report a case in which a lung cancer drug damaged the heart in a way that looked like the cancer's return. The patient was a 77-year-old man who had one lung removed for cancer. Five months into the targeted drug, he grew breathless with fluid around the remaining lung.
Fluid around the lung after cancer surgery often signals spread. Here the fluid was of the watery kind not made by tumors. Heart scans showed the heart's pumping had dropped sharply. The drug is known to harm the heart in a share of patients. Stopping it let the heart recover, as the title notes. The case warns teams to test heart function before blaming the cancer. A wrong call could have meant needless cancer treatment.
Catalog record
| CREATOR | Hirona Yokoyama, Nobuhito Hara, Rika Sasaki, Yumi Yoshii, Masahide Ota, Shunsuke Okazaki, Hitoshi Nakagawa, Takeshi Kawaguchi, Masatsugu Hamaji, Yuji Nitta, Maiko Takeda, Masayuki Takeda |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |